Similarly, PSGR/OR51E2 has been tied to cancer cell invasiveness (Sanz et al., 2014) and is a tumor antigen recognized by CD8+ T cells (Matsueda et al., 2012). The gene discussed is OR51E2; the disease is neoplasm.